# Incyte Corporation (INCY): MoatMap facts

As of 14 Oct 2026. Research data, not investment advice.

As of 14 Oct 2026, MoatMap's StockRank for Incyte Corporation (INCY) is 93/100, ranked against 24,000+ stocks in 35 markets (Quality 88, Value 53, Momentum 56, each scored against its sector).

- StockRank: 93/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 88, Value 53, Momentum 56: each a 0-100 percentile within the stock's sector.
- Position: #1,845 overall, #206 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 111.36 USD on 12 Oct 2026.
- Insider filings, last 180 days: directors sold USD 20.1M.

Source: https://moatmap.ai/stock/INCY
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker